Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

Advancing Outbreak Detection, Notification, and Response Capacity by Implementing 7-1-7 in Partner Countries

Active
CDC-RFA-JG-26-0214Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This funding opportunity supports the strengthening of national systems in partner countries to achieve the 7-1-7 target for outbreak detection, notification, and response, with the goal of containing biological threats before they spread across borders. Activities are focused on enhancing early warning surveillance, expanding laboratory capacity, improving information sharing across sectors and international boundaries, and building robust response operations to minimize health and economic impacts. The initiative leverages lessons from past global health emergencies to protect both U.S. interests and the health security of recipient nations by promoting efficient, accountable, and sustainable systems that reduce reliance on external support over time. Funded through the Centers for Disease Control and Prevention under the U.S. Department of Health and Human Services, this solicitation is open to applicants seeking to implement activities exclusively outside the United States and its territories. Applications must be submitted by August 14, 2026, under solicitation number CDC-RFA-JG-26-0214, with inquiries directed to the designated point of contact at the CDC. The program emphasizes burden sharing and long-term self-reliance, aiming to foster resilient health systems that not only safeguard local populations but also enhance global health security in alignment with American strategic interests.

General Info

Strengthen national systems for outbreak detection and response to enhance global health security and self-reliance.

Agency

Department Of Health And Human Services → Centers For Disease Control-GhcView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(1)

CDC-RFA-JG-26-0214 Enhancing Timeliness of Outbreak Detection NOFO

PDFrfp

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Centers For Disease Control-Ghc
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Health And Human Services → Centers For Disease Control-Ghc
View Agency Profile
Office AddressUS
Contacts
Centers for Disease Control-GHC

Full Description

Show more
This Notice of Funding Opportunity (NOFO) supports strengthening country systems to detect, notify, and respond to outbreaks in alignment with the 7-1-7 target. Activities under this award are intended for implementation outside the United States and its territories. Building on previous outbreak experience and other international health emergencies, this NOFO advances American interests by reinforcing systems that protect both the United States and recipient nations. Activities focus on improving early detection of biological threats, timely notification across sectors and borders, and effective response to contain outbreaks before they spread. Efforts include strengthening surveillance, expanding laboratory readiness, enhancing information flows, and improving response operations to reduce health and economic effects. These activities emphasize burden sharing, accountability, and efficiency to ensure benefits to Americans at home and abroad, while supporting recipient nations in achieving long-term self-reliance and stability.

Similar Contracts

NAICS: 541714
New
Grant
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)The National Cancer Institute is soliciting R33 grant applications to support the advanced development and rigorous validation of emerging technologies aimed at advancing cancer research and clinical care. This opportunity is intended for projects that have already addressed major feasibility barriers, as demonstrated by strong preliminary data, but require further refinement, optimization, and technical validation to achieve broad adoption within the scientific community. The focus is on technologies with new or substantially improved capabilities for measuring, analyzing, modeling, or interrogating cancer-related biological systems, including advanced molecular and cellular platforms, multi-omic and spatial profiling methods, next-generation imaging and sensing tools, immuno-engineering approaches, and innovations in biospecimen handling and quality assessment. Proposals must center on cancer-specific applications, and applications that merely apply established technologies to novel biological questions without technological innovation are not eligible. This funding opportunity is part of the NCI’s Innovative Molecular Analysis Technologies Program and explicitly prohibits clinical trials. The goal is to accelerate progress in areas such as cancer biology, early detection, diagnosis, treatment, control, and epidemiology by enabling technologies that offer transformative potential for the research community. Projects must demonstrate clear potential for widespread utility in cancer research while maintaining a tight focus on technical advancement rather than application-specific hypotheses. All applications must be submitted through the designated grants portal, and inquiries should be directed to the IMAT Program Contact provided. The opportunity was posted in July 2026 and is open to applicants seeking to bridge the gap between initial innovation and scalable adoption in cancer science.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Federal
Multiscale Reasoning For Human Physiology RFIThe Defense Advanced Research Projects Agency’s Biological Technologies Office is seeking input on cutting-edge technologies that enable multiscale reasoning across human physiology through this Request for Information, identified as DARPA-SN-26-100. The focus is on emerging tools including artificial intelligence systems, foundation models, computational frameworks, and datasets capable of integrating biological, physiological, and clinical data across multiple scales—from molecular and cellular levels to organ systems and whole-body responses. The goal is to advance the ability to model, predict, and interpret complex human physiological behavior using AI and data-driven approaches, with interest in non-traditional performers and innovative solutions from industry, academia, government labs, and healthcare organizations. Responses are due by August 10, 2026, and the solicitation falls under NAICS code 541714 for research and development in the physical, engineering, and life sciences. All submissions should be directed to Dr. Roozbeh Jafari, Program Manager at DARPA/BTO, via bioreasoning@darpa.mil. The office is located in Arlington, Virginia, and while no specific place of performance is defined, selected technologies may be developed and evaluated through future DARPA programs. This RFI does not constitute a solicitation for proposals or obligations but aims to inform upcoming funding opportunities in the field of physiological modeling and AI-driven biological insight.
Defense Advanced Research Projects Agcy

POSTED

1 day ago

DEADLINE

in 26 days
View Details